Cargando…
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease
BACKGROUND AND AIMS: To investigate the efficacy and safety of three different dosages of embryonated, viable eggs of Trichuris suis [TSO] versus placebo for induction of remission in mildly-to-moderately active ileocolonic, uncomplicated Crohn’s disease [CD]. METHODS: Adults with active CD [n = 252...
Autores principales: | Schölmerich, Jürgen, Fellermann, Klaus, Seibold, Frank W., Rogler, Gerhard, Langhorst, Jost, Howaldt, Stefanie, Novacek, Gottfried, Petersen, Andreas Munk, Bachmann, Oliver, Matthes, Harald, Hesselbarth, Norbert, Teich, Niels, Wehkamp, Jan, Klaus, Jochen, Ott, Claudia, Dilger, Karin, Greinwald, Roland, Mueller, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881737/ https://www.ncbi.nlm.nih.gov/pubmed/27707789 http://dx.doi.org/10.1093/ecco-jcc/jjw184 |
Ejemplares similares
-
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018) -
Preventive Trichuris suis ova (TSO) treatment protects immunocompetent rabbits from DSS colitis but may be detrimental under conditions of immunosuppression
por: Leonardi, Irina, et al.
Publicado: (2017) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013) -
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
por: Yordanova, Ivet A., et al.
Publicado: (2021)